Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its proprietary GelVac(TM) vaccine ...
As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European markets Raanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon ...
A nasal-spray COVID-19 vaccine could prevent more infections of fast-spreading variants. Here’s why the science is taking so long. The COVID-19 vaccines that we now have are very good at blunting the ...
LONDON--(BUSINESS WIRE)--The global nasal implants market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio. The ...
PRINCETON, N.J., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback